Molecular basis of congenital myasthenic syndromes: Mutations in the acetylcholine receptor

Andrew G Engel, Kinji Ohno, Hai Long Wang, Margherita Milone, Steven M Sine

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The congenital myasthenic syndromes include end-plate (EP) acetylcholinesterase deficiency, presynaptic abnormalities affecting the evoked release or size of transmitter quanta, and acetylcholine (ACh) receptor (AChR) channelopathies stemming from a kinetic abnormality and/or deficiency of AChR. A kinetic abnormality predicts, and AChR deficiency may predict, one or more mutations in an AChR subunit gene. These clues have led to the identification of 53 mutations in different subunits of AChR in 55 kinships of the congenital myasthenic syndromes. The mutations either increase or decrease the response to ACh, produce AChR deficiency, or both. In the slow-channel syndromes, prolonged opening episodes of AChR cause cationic overloading of the EP and an EP myopathy; the mutations occur in different subunits and different domains of the subunits and have dominant positive effects. The M1 and M2 mutations slow channel closure, increase apparent affinity for ACh, and variably enhance desensitization, and the extracellular αG153S enhances affinity for ACh, promoting reopening of the diliganded receptor. In the low-affinity fast-channel syndrome, εP121L reduces affinity for ACh and reopening of the diliganded receptor, resulting in a decreased response to ACh and shorter burst durations. Severe EP AChR deficiency results from heterozygous or homozygous mutations that terminate translation prematurely; these are concentrated in the ε subunit, probably because substitution of the fetal γ for the adult ε subunit can rescue the phenotype from fatal null mutations in ε. Variable AChR deficiency and variable functional abnormalities stem from heteroallelic nonsense and missense mutations in AChR subunit genes.

Original languageEnglish (US)
Pages (from-to)185-194
Number of pages10
JournalNeuroscientist
Volume4
Issue number3
DOIs
StatePublished - May 1998

Fingerprint

Congenital Myasthenic Syndromes
Cholinergic Receptors
Mutation
Acetylcholine
Channelopathies
Nonsense Codon
Muscular Diseases
Missense Mutation
Acetylcholinesterase
Genes

Keywords

  • Acetylcholine receptor
  • Congenital myasthenic syndromes
  • Mutation analysis
  • Neuromuscular junction
  • Patch-clamp analysis

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Molecular basis of congenital myasthenic syndromes : Mutations in the acetylcholine receptor. / Engel, Andrew G; Ohno, Kinji; Wang, Hai Long; Milone, Margherita; Sine, Steven M.

In: Neuroscientist, Vol. 4, No. 3, 05.1998, p. 185-194.

Research output: Contribution to journalArticle

@article{b8e9fe57dc3e486cb8816c071166f94a,
title = "Molecular basis of congenital myasthenic syndromes: Mutations in the acetylcholine receptor",
abstract = "The congenital myasthenic syndromes include end-plate (EP) acetylcholinesterase deficiency, presynaptic abnormalities affecting the evoked release or size of transmitter quanta, and acetylcholine (ACh) receptor (AChR) channelopathies stemming from a kinetic abnormality and/or deficiency of AChR. A kinetic abnormality predicts, and AChR deficiency may predict, one or more mutations in an AChR subunit gene. These clues have led to the identification of 53 mutations in different subunits of AChR in 55 kinships of the congenital myasthenic syndromes. The mutations either increase or decrease the response to ACh, produce AChR deficiency, or both. In the slow-channel syndromes, prolonged opening episodes of AChR cause cationic overloading of the EP and an EP myopathy; the mutations occur in different subunits and different domains of the subunits and have dominant positive effects. The M1 and M2 mutations slow channel closure, increase apparent affinity for ACh, and variably enhance desensitization, and the extracellular αG153S enhances affinity for ACh, promoting reopening of the diliganded receptor. In the low-affinity fast-channel syndrome, εP121L reduces affinity for ACh and reopening of the diliganded receptor, resulting in a decreased response to ACh and shorter burst durations. Severe EP AChR deficiency results from heterozygous or homozygous mutations that terminate translation prematurely; these are concentrated in the ε subunit, probably because substitution of the fetal γ for the adult ε subunit can rescue the phenotype from fatal null mutations in ε. Variable AChR deficiency and variable functional abnormalities stem from heteroallelic nonsense and missense mutations in AChR subunit genes.",
keywords = "Acetylcholine receptor, Congenital myasthenic syndromes, Mutation analysis, Neuromuscular junction, Patch-clamp analysis",
author = "Engel, {Andrew G} and Kinji Ohno and Wang, {Hai Long} and Margherita Milone and Sine, {Steven M}",
year = "1998",
month = "5",
doi = "10.1177/107385849800400314",
language = "English (US)",
volume = "4",
pages = "185--194",
journal = "Neuroscientist",
issn = "1073-8584",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Molecular basis of congenital myasthenic syndromes

T2 - Mutations in the acetylcholine receptor

AU - Engel, Andrew G

AU - Ohno, Kinji

AU - Wang, Hai Long

AU - Milone, Margherita

AU - Sine, Steven M

PY - 1998/5

Y1 - 1998/5

N2 - The congenital myasthenic syndromes include end-plate (EP) acetylcholinesterase deficiency, presynaptic abnormalities affecting the evoked release or size of transmitter quanta, and acetylcholine (ACh) receptor (AChR) channelopathies stemming from a kinetic abnormality and/or deficiency of AChR. A kinetic abnormality predicts, and AChR deficiency may predict, one or more mutations in an AChR subunit gene. These clues have led to the identification of 53 mutations in different subunits of AChR in 55 kinships of the congenital myasthenic syndromes. The mutations either increase or decrease the response to ACh, produce AChR deficiency, or both. In the slow-channel syndromes, prolonged opening episodes of AChR cause cationic overloading of the EP and an EP myopathy; the mutations occur in different subunits and different domains of the subunits and have dominant positive effects. The M1 and M2 mutations slow channel closure, increase apparent affinity for ACh, and variably enhance desensitization, and the extracellular αG153S enhances affinity for ACh, promoting reopening of the diliganded receptor. In the low-affinity fast-channel syndrome, εP121L reduces affinity for ACh and reopening of the diliganded receptor, resulting in a decreased response to ACh and shorter burst durations. Severe EP AChR deficiency results from heterozygous or homozygous mutations that terminate translation prematurely; these are concentrated in the ε subunit, probably because substitution of the fetal γ for the adult ε subunit can rescue the phenotype from fatal null mutations in ε. Variable AChR deficiency and variable functional abnormalities stem from heteroallelic nonsense and missense mutations in AChR subunit genes.

AB - The congenital myasthenic syndromes include end-plate (EP) acetylcholinesterase deficiency, presynaptic abnormalities affecting the evoked release or size of transmitter quanta, and acetylcholine (ACh) receptor (AChR) channelopathies stemming from a kinetic abnormality and/or deficiency of AChR. A kinetic abnormality predicts, and AChR deficiency may predict, one or more mutations in an AChR subunit gene. These clues have led to the identification of 53 mutations in different subunits of AChR in 55 kinships of the congenital myasthenic syndromes. The mutations either increase or decrease the response to ACh, produce AChR deficiency, or both. In the slow-channel syndromes, prolonged opening episodes of AChR cause cationic overloading of the EP and an EP myopathy; the mutations occur in different subunits and different domains of the subunits and have dominant positive effects. The M1 and M2 mutations slow channel closure, increase apparent affinity for ACh, and variably enhance desensitization, and the extracellular αG153S enhances affinity for ACh, promoting reopening of the diliganded receptor. In the low-affinity fast-channel syndrome, εP121L reduces affinity for ACh and reopening of the diliganded receptor, resulting in a decreased response to ACh and shorter burst durations. Severe EP AChR deficiency results from heterozygous or homozygous mutations that terminate translation prematurely; these are concentrated in the ε subunit, probably because substitution of the fetal γ for the adult ε subunit can rescue the phenotype from fatal null mutations in ε. Variable AChR deficiency and variable functional abnormalities stem from heteroallelic nonsense and missense mutations in AChR subunit genes.

KW - Acetylcholine receptor

KW - Congenital myasthenic syndromes

KW - Mutation analysis

KW - Neuromuscular junction

KW - Patch-clamp analysis

UR - http://www.scopus.com/inward/record.url?scp=0031837418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031837418&partnerID=8YFLogxK

U2 - 10.1177/107385849800400314

DO - 10.1177/107385849800400314

M3 - Article

AN - SCOPUS:0031837418

VL - 4

SP - 185

EP - 194

JO - Neuroscientist

JF - Neuroscientist

SN - 1073-8584

IS - 3

ER -